Literature DB >> 12430146

In situ light dosimetry during photodynamic therapy of Barrett's esophagus with 5-aminolevulinic acid.

Robert L P van Veen1, Maurice C G Aalders, Kasper L Pasma, Peter D Siersema, Jelle Haringsma, Wim van de Vrie, Edward E E Gabeler, Dominic J Robinson, Henricus J C M Sterenborg.   

Abstract

BACKGROUND AND OBJECTIVES: Previous studies with PhotoDynamic Therapy (PDT) in bladder and bronchi have shown that due to scattering and reflection, the actually delivered fluence rate on the surface in a hollow organ can be significantly higher than expected. In this pilot study, we investigated the differences between the primary calculated and the actual measured fluence rate during PDT of Barrett's Esophagus (BE) using 23 independent clinical measurements in 15 patients. STUDY DESIGN/
MATERIALS AND METHODS: A KTP-dye module laser at 630 nm was used as light source. Light delivery was performed using a cylindrical light diffuser inserted in the center of an inflatable transparent balloon with a length corresponding to the length of the Barrett's epithelium. The total light output power of the cylindrical diffuser was calibrated using an integrating sphere to deliver a primary fluence rate of 100 mW cm(-2). Two fiber-optic pseudo sphere isotropic detectors were placed on the balloon and were used to measure fluence rate at the surface of the esophageal wall during PDT. RESULTS AND
CONCLUSIONS: The actual fluence rate measured was 1.5-3.9 times higher than the primary fluence rate for 630 nm. In general, the fluence rate amplification factor decreased with increasing redness of the tissue and was less for shorter diffusers. Fluence rate variations in time were observed which coincided with patients coughing, movement, and esophageal spasms. These factors combined with inter patient variability of the fluence rate measured appears to justify the routine application of this technique in PDT of BE. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12430146     DOI: 10.1002/lsm.10129

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  5 in total

Review 1.  A systematic review and meta-analysis of the treatment for Barrett's esophagus.

Authors:  You-Ming Li; Lan Li; Chao-Hui Yu; You-Shi Liu; Cheng-Fu Xu
Journal:  Dig Dis Sci       Date:  2008-04-22       Impact factor: 3.199

Review 2.  Photodynamic therapy in dermatology beyond non-melanoma cancer: An update.

Authors:  Xiang Wen; Yong Li; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2017-06-21       Impact factor: 3.631

3.  5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial.

Authors:  M Hage; P D Siersema; H van Dekken; E W Steyerberg; J Haringsma; W van de Vrie; T E Grool; R L P van Veen; H J C M Sterenborg; E J Kuipers
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

4.  How light dosimetry influences the efficacy of photodynamic therapy with 5-aminolaevulinic acid for ablation of high-grade dysplasia in Barrett's esophagus.

Authors:  Gary D Mackenzie; Neil F Jamieson; Marco R Novelli; C Alexander Mosse; Benjamin R Clark; Sally M Thorpe; Stephen G Bown; Laurence B Lovat
Journal:  Lasers Med Sci       Date:  2007-07-03       Impact factor: 3.161

5.  Measurement of Cyanine Dye Photobleaching in Photosensitizer Cyanine Dye Conjugates Could Help in Optimizing Light Dosimetry for Improved Photodynamic Therapy of Cancer.

Authors:  Nadine S James; Ravindra R Cheruku; Joseph R Missert; Ulas Sunar; Ravindra K Pandey
Journal:  Molecules       Date:  2018-07-24       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.